Arturo Molina M.D., Chief Medical Officer at Protagonist Therapeutics, Inc (PTGX), sold 5,424 shares at $84.77 ($460K) on 2025-11-17, disclosed to the SEC on 2025-11-19.
Open-market sale of $460k PTGX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.77 | 2,712 | $230K | 50.0% |
| 2 | $84.77 | 2,712 | $230K | 50.0% |
| Total | $84.77 avg | 5,424 | $460K | 100% |
| Filing → |
| PTGX | SELL | 2026-01-21 | $785K | — | Filing → |
| PTGX | SELL | 2025-06-11 | $1.1M | — | Filing → |
| PTGX | SELL | 2025-03-14 | $3.4M | — | Filing → |